For Immediate Release
2012-2013 American Society of Cytopathology
Executive Board and Officers
November 4, 2012, Wilmington, Delaware–The American Society of Cytopathology will be announcing its new officers and Executive Board members for 2012-2013 as follows, during the ASC Annual Business Meeting on November 4th in Las Vegas, during the ASC 60th Annual Scientific Meeting.
American Society of Cytopathology Officers
President
Andrew Renshaw, MD
Baptist Hospital of Miami
Department of Pathology
Miami Florida
Vice-President
Michael R. Henry, MD
Mayo Clinic and Foundation
Rochester, Minnesota
President-Elect
Ritu Nayar, MD
Northwestern Memorial Hospital
Chicago, Illinois
Secretary-Treasurer
Daniel F.I. Kurtycz, MD
Wisconsin State Laboratory of Hygiene
Madison, Wisconsin
ASC Executive Board Members
Joel S. Bentz, MD (2013)
Laboratory Medicine Consultants, Ltd.
Las Vegas, Nevada
Jill L. Caudill, MEd, SCT(ASCP)CM (2013)
Mayo School of Health-Related Sciences
Rochester, Minnesota
Eva M. Wojcik, MD, MIAC (2013)
Loyola University Medical Center
Maywood, Illinois
Rosemary Tambouret, MD (2014)
Massachusetts General Hospital
Boston, Massachusetts
Amy J. Wendel Spiczka, MS, SCT, MB, HTL(ASCP)CM (2014)
Mayo Clinic and Foundation
Scottsdale, Arizona
Philip T. Valente, MD (2014)
University of Texas Health Science Center
San Antonio, Texas
David F. Chhieng, MD (2015)
Yale University
New Haven, Connecticut
Jeffrey F. Krane, MD (2015)
Brigham & Women's Hospital
Boston, Massachusetts
Lynnette C. Savaloja, SCT(ASCP) (2015)
Regions Hospital
Saint Paul, Minnesota
Tarik Elsheik, MD (2016)
Cleveland Clinic Foundation
Cleveland, Ohio
Kalyani Naik, MS, SCT(ASCP) (2016)
University of Michigan Hospital
Ann Arbor, Michigan
Patricia Wasserman, MD (2016)
Columbia University Medical Center
New York, New York
Lydia Howell, MD, Past President
University of California
Davis Medical Center
Sacramento, California
Ann T. Moriarty, MD, ex officio
ASC Foundation Co-Chair
Ameripath
Indianapolis, Indiana
William N. Crabtree, PhD, SCT(ASCP),ex officio
ASC Foundation Co-Chair
Indiana University School of Medicine
Indianapolis, Indiana
The Officers and new Executive Board Members will be installed on November 4, 2012 during the ASC’s 60th Annual Scientific Meeting. The ASC Executive Board is the general management of the American Society of Cytopathology. The Board regularly performs the ordinary duties of a board of directors to appoint any Committee it may deem necessary and to delegate whatever powers necessary to the Committees. Executive Board Members are elected to serve a four-year term on the Board.
The ASC, founded in 1951, is a distinguished national professional society of physicians, cytotechnologists and scientists who are dedicated to the detection and early diagnosis of nearly all forms of cancer. The ASC is the largest medical society solely devoted to recognizing cellular abnormalities in order to benefit patients. The majority of tests that the ASC Members interpret are Pap tests. The ASC’s diverse membership of more than 3000 individuals includes representatives from other countries who share a vision of education, research and continuous improvement in the standards and quality of patient care. The ASC is a unique society that provides a forum where physicians and cytotechnologists can interact and network with each other on both a personal and professional level.
Additional information on the American Society of Cytopathology may be obtained from:
American Society of Cytopathology, 100 West 10th Street, Suite 605, Wilmington, DE 19801; telephone: (302) 543-6583, fax: (302) 543-6597, e-mail: , web site: www.cytopathology.org.

